세계의 싱글셀 오믹스 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년)

The global demand for Single-cell Omics Market is presumed to reach the market size of nearly USD 18.64 BN by 2030 from USD 3.9 BN in 2022 with a CAGR of 21.6% under the study period 2023 - 2030.

Single-cell omics, often referred to as single-cell analysis or single-cell genomics, is a cutting-edge field in molecular biology and genomics that focuses on studying individual cells at the molecular level.

MARKET DYNAMICS:

The single-cell omics market is experiencing robust growth driven by multiple scientific, technological, and clinical factors. Technological advancements have played a pivotal role, enabling more efficient, accurate, and cost-effective analysis of individual cells. Researchers are increasingly drawn to single-cell omics to unravel the complexity of cellular heterogeneity, especially within seemingly uniform cell populations, driving market expansion. It is particularly valuable in disease research, offering insights into the molecular underpinnings of various conditions, including cancer and neurodegenerative diseases. It holds great promise in advancing precision medicine by identifying disease-specific markers and potential therapeutic targets. Furthermore, the field has found applications in developmental biology, immunology, drug discovery, and clinical diagnostics. Its impact extends to biotechnology, biomedical research, and academic institutions. Collaborations between academia, industry, and healthcare institutions are accelerating the development and commercialization of single-cell omics technologies and applications. As regulatory support and data analysis tools advance, the market continues to evolve, positioning single-cell omics as a crucial tool for understanding biology, disease, and personalized medicine.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of single-cell omics. The growth and trends of single-cell omics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the single-cell omics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Single-Cell Genomics
• Single-Cell Transcriptomics
• Single-Cell Proteomics
• Single-Cell Metabolomics

By Application

• Oncology
• Cell Biology
• Neurology
• Immunology
• Other Applications

By End-User

• Academic And Research Organizations
• Pharmaceutical & Biotechnology Companies
• Hospital And Diagnostic Laboratories
• Other End-Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Single-cell Omics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Single-cell Omics market include Cellenion, PerkinElmer Inc., 10x Genomics, ANGLE plc, Illumina Inc., and Bio-Rad Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SINGLE-CELL OMICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SINGLE-CELL OMICS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Single-Cell Genomics Historic and Forecast Sales by Regions
• 5.5 Single-Cell Transcriptomics Historic and Forecast Sales by Regions
• 5.6 Single-Cell Proteomics Historic and Forecast Sales by Regions
• 5.7 Single-Cell Metabolomics Historic and Forecast Sales by Regions

6 . GLOBAL SINGLE-CELL OMICS MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Oncology Historic and Forecast Sales by Regions
• 6.5 Cell Biology Historic and Forecast Sales by Regions
• 6.6 Neurology Historic and Forecast Sales by Regions
• 6.7 Immunology Historic and Forecast Sales by Regions
• 6.8 Other Historic and Forecast Sales by Regions

7 . GLOBAL SINGLE-CELL OMICS MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-User
• 7.4 Academic And Research Organizations Historic and Forecast Sales by Regions
• 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.6 Hospital And Diagnostic Laboratories Historic and Forecast Sales by Regions
• 7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL SINGLE-CELL OMICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SINGLE-CELL OMICS COMPANIES

• 9.1. Single-Cell Omics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF SINGLE-CELL OMICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Cellenion
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. PerkinElmer Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. 10x Genomics
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. ANGLE plc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Illumina Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Bio-Rad Laboratories Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies